Postscript

Introduction

  • Pancytopenia is defined as a decrease in all three blood cell lines.
  • Pancytopenia can be associated with a multitude of disease states, some of which are life-threatening.
  • Patients may be asymptomatic or they may present with symptoms related to the cytopenias or the underlying disease causing the cytopenias.
  • Pancytopenia is one of the most common reasons for consultation from hematologists. 
  • Pancytopenia is not a disease in itself but rather a finding due to an underlying disease process affecting the bone marrow or the peripheral cell lines.
  • Note: Many disorders that cause pancytopenia can also cause bicytopenia.

Definitions

  • Pancytopenia is defined as a decrease in all three blood cell lines:
    • Anemia is defined as Hb < 12 g/dL in women, < 13 g/dL in men
    • Leukopenia is defined as white blood cell count < 3.6 x 109/L
      • Neutropenia is defined as absolute neutrophil count < 1.8 x 109/L
    • Thrombocytopenia is defined as platelet count < 150 x 109/L

Classification

  • Pancytopenia may be:
    • Inherited vs acquired
    • Transient or acquired
    • Mild, moderate or severe
    • Pancytopenia may be malignant or benign
  • Mechanistic classification:
    • Bone marrow underproduction
    • Bone marrow infiltration
    • Destruction
    • Sequestration

Causes of pancytopenia (according to predominant mechanism

  • Impaired production – reduced to absent hematopoiesis
    • Congenital aplastic anemia:
      • Fanconi anemia
      • Shwachman-Diamond syndrome
      • Dyskeratosis congenita
      • Congenital amegakaryocytic thrombocytopenia
      • HLH
    • Acquired aplastic anemia
      • Idiopathic (immune-mediated) – the majority of cases (70%-80%)
      • PNH
      • Hypoplastic MDS
      • Drugs:
        • Chloramphenicol
        • NSAIDs
        • Antithyroid drugs:
          • Methimazole
          • Propylthiouracil
          • Methylthiouracil
        • Corticosteroids
        • Penicillamine
        • Allopurinol
        • Gold
        • Ticlopidine
        • Antihistamines:
          • Cimetidine
          • Ranitidine
          • Chlorpheniramine
        • Lithium
      • Chemicals
        • Benzene
        • Insecticides
        • Potassium perchlorate
        • Hydrocarbon-based glue vapors
      • Radiation – bone marrow hypoplasia develops at cumulative doses > 5 Gy
      • Alcohol
      • Infections:
        • Parvovirus B19
        • HIV
        • Hepatitis – typically non-A, non-B, non-C, non-G hepatitis
        • Epstein Barr virus
        • Cytomegalovirus
        • Herpes simplex virus
        • Herpes zoster
        • Adenovirus
      • Pregnancy
      • Copper deficiency
      • HLH
      • Medical disorders:
        • Graves disease
        • Eosinophilic fasciitis
        • Thymoma and thymic carcinoma
  • Bone marrow infiltrative (replacement) disorders
    • Cells:
      • Benign:
        • B12 deficiency
        • Folate deficiency
      • Malignant:
        • Metastatic cancer
        • Hematological
          • Leukemias:
            • Acute leukemias
            • Chronic leukemias/myeloproliferative neoplasms (MPN)
          • Myelodysplastic syndromes (MDS)
          • Multiple myeloma
    • Extracellular substances
      • Collagen (fibrotic diseases):
        • Primary myelofibrosis
        • Malignant lymphomas
        • Autoimmune fibrosis
      • Granulomas:
        • Sarcoidosis
        • Disseminated miliary tuberculosis
      • Storage diseases:
        • Gaucher disease
      • Anorexia nervosa with gelatinous degeneration
  • Peripheral destruction
    • Autoimmune hemolytic pancytopenia, especially SLE
  • Sequestration – hypersplenism:
    • Portal hypertension/cirrhosis
    • Infections (eg, EBV)
    • Autoimmune disorders (eg, SLE, RA/Felty syndrome)
    • Malignancies (eg, lymphomas, MPN)
    • Myelofibrosis with myeloid metaplasia
    • Storage diseases (eg, Gaucher)

Note: many of the underlying causes involve multiple mechanisms that result in pancytopenia

Clinical presentation

  • Patients may be diagnosed incidentally with a complete blood count.
  • Patients  may present with symptoms related to:
    • Cytopenias:
      • Anemia:
        • Fatigue
        • Shortness of breath
        • Exercise intolerance
        • Chest pain 
        • Headache
      • Leukopenia:
        • Fevers
        • Chills
        • Symptoms of focal infection
      • Thrombocytopenia:
        • Petechiae
        • Purpura
        • Bleeding
    • Underlying cause of the pancytopenia
  • History should address:
    • Chronicity of pancytopenia
    • Constitutional symptoms, including fevers, night sweats, and/or weight loss
    • Nausea, vomiting, and jaundice that may be associated with liver disease
    • Alcohol intake
    • Medications
    • Personal and occupational exposures 

Diagnosis

  • Diagnosis confirmed by complete blood count showing reduction in all three blood cell types.
  • Other tests include:
    • Reticulocyte count:
      • Low in most cases
      • May be elevated in patients with:
        • Hypersplenism 
        • Autoimmune pancytopenia

 

    • Peripheral smear

  • Other labs as shown in graphic:

 

Treatment

  • Regardless of the underlying cause of pancytopenia, patients who are clinically unstable from their low counts require urgent stabilization and may need hospitalization with supportive therapy including:
    • Blood transfusions
    • Antibiotics
    • Cytokines:
      • G-CSF
      • t-PO receptor agonists
  • Treatment is geared towards the underlying disease.
Prev
 1 / 0 
Next